XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets, net
9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, net

Note 8 — Intangible Assets, net

 

Intangible assets, less accumulated amortization, consisted of the following as of:

 

   Estimated Useful Life  September 30, 2022   December 31, 2021 
Defensive asset  60 months  $2,105   $2,105 
Laboratory licenses and certifications and laboratory information management software  24 months   3,200     
Other  1 year   70    70 
Total Intangible assets      5,375    2,175 
Less Accumulated Amortization      (1,425)   (146)
Intangible Assets, net     $3,950   $2,029 

 

The defensive technology intangible asset was recognized upon its acquisition of CapNostics, LLC, an unrelated third-party, for total purchase consideration paid on the October 5, 2021 acquisition date of approximately $2.1 million in cash. The CapNostics LLC transaction was accounted for as an asset acquisition, resulting in the recognition of the defensive technology intangible asset. The defensive technology intangible asset is being amortized on a straight-line basis over an expected useful life 60 months commencing on the acquisition date.

 

The intangible assets recognized under the APA-RDx are the laboratory licenses and certifications, inclusive of a CLIA certification, CAP accreditation, and clinical laboratory licenses for five (5) U.S. States transfer to the Company from RDx, and a laboratory information management software perpetual-use royalty-free license granted under the APA-RDx, with such intangible asset having a useful life of twenty-four months commencing on the APA-RDx February 25, 2022 transaction date.

 

Amortization expense of the intangible assets discussed above was $505 and $17 for the three month periods ended September 30, 2022 and 2021, respectively, and $1,278 and $23 for the nine month periods ended September 30, 2022 and 2021, respectively, and is included in general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations. As of September 30, 2022, the estimated future amortization expense associated with the Company’s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:

 

      
2022 (remainder of year)  $504 
2023   2,021 
2024   688 
2025   421 
2026   316 
Total  $3,950